Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Arjo AB is a Swedish company operating in the medical technology industry, specializing in products and solutions that improve the quality of life for patients with reduced mobility and age-related health challenges. The company's offerings include medical beds, patient transfer systems, hygiene systems, and pressure injury prevention products. Founded in 1957, Arjo has a long history in healthcare solutions and is headquartered in Malmö, Sweden. The company operates globally, with a significant presence in Europe, North America, and other regions. Arjo's competitive strength lies in its focus on enhancing patient outcomes and caregiver efficiency through innovative and ergonomic healthcare solutions.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Arjo ABAbbVie
Last price
kr 33.78$294.89
Currency
SEK
USD
kr 9.2B$521B
25.4950.77
kr 1.33$5.81
0.69-
kr 0.95$6.83
2.81%2.35%
Sector
HealthHealth
Employees
7,00057,000
Ticker
Skr ARJO B$ABBV
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrARJO B or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.